NX1.ASX Announces Trading Halt
Key points
- Trading in NX1.ASX securities halted at company's request
- Halt pending announcement regarding debt funding facility
- Expected announcement before May 26, 2026
- Halt to remain until announcement release or May 26, 2026
Full summary
Nexalis Therapeutics Ltd (ASX: NX1) has requested a trading halt on its securities to manage its continuous disclosure obligations. The halt is necessary pending an announcement related to its existing debt funding facility. The company expects to release the announcement before the commencement of normal trading on Tuesday, May 26, 2026. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on May 26, 2026, or when the announcement is released to the market.
Summary generated by a large language model. Please interpret with care.